Clinical Trial Update: Benralizumab for Eosinophilic Gastritis (BEGS) [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial evaluating benralizumab for eosinophilic gastritis or gastroenteritis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Eosinophilic Gastritis
• Gastroenteritis

Drugs mentioned

• Benralizumab (benralizumab)

Snippet

Sponsor: Children's Hospital Medical Center, Cincinnati | Conditions: Eosinophilic Gastritis or Gastroenteritis | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2021-08-17